The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease

NCT01809574 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2015-04-09

No results posted yet for this study

Summary

We hypothesized that the multi-disciplinary assessment of interstitial lung disease patients would lead to a more accurate diagnosis and consequently alterations in treatment regimens that may lead to improved outcomes.

Conditions

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • David Shitrit, Dr · Head of Pulmonary departmant, Meir Medical Center.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01809574 on ClinicalTrials.gov